Mehmet Ali ERKURT, Irfan KUKU, Mustafa KOROGLU, Ilhami BERBER, Recep BENTLİ, Ilknur NİZAM, Emin KAYA

Haploidentical Transplantation Experience in Turgut Ozal Medical Center: Case Report and a Review of Literature

Haploidentik kök hücre nakli HLA uyumlu donörü olmayan hastalar için başka bir alternatif nakil modelidir. Hala, allojenik nakil gereksinimi olan hastaların ancak üçte biri HLA uyumlu vericiye sahiptir. Acil kök hücre nakli gereksiniminde haploidentik nakil bir çok hasta için önemli bir çözüm yoludur. Daha önceleri haploidentik hematopoetik kök hücre nakli yüksek oranda graft rejeksiyonu, graft versus host hastalığı, graft başarısızlığı ve nakil ile ilgili mortalite ile karakterize idi, fakat T hücre deplesyonundaki yeni gelişmeler ve mega doz kök hücre nakli yönetimi haploidentik kök hücre naklinde bazı problemlere çözüm oldu. Biz bir vakaya uygulanan Turgut Özal Tıp Merkezi' ndeki haploidentik kök hücre nakli deneyimimizi sunduk.

Turgut Özal Tıp Merkezi'ndeki Haploidentik Nakil Deneyimimiz: Olgu Sunumu ve Literatür Sunumu

Haploidentical hematopoietic stem-cell transplantation is an optional transplant modality for patients without a Human Leukocyte Antigensmatched donor. Still, one-third of patients who might benefit from allogeneic transplantation are able to find a Human Leukocyte Antigensmatched related donor. In need of immediate stem-cell transplantation, haploidentical donor is an important solution for many patients. Previously, haploidentical hematopoietic stem-cell transplantation was characterised by a high rejection rate, graft-versus-host disease, graft failure, and transplant-related mortality, but there have since been significant improvements in some areas. Development of new extensive T-cell depletion methods with megadose stem cell administration have overcome problems of haploidentical hematopoietic stem-cell transplantation. We presented an applied case haploidentical hematopoietic stem-cell transplantation as an experience in Turgut Ozal Medical Center.

PDF

___

Aversa F. New Forms of Transplantation: Haploidentical Transplants. Bone Marrow Transplantation 2001;28:16-7.
Reisner Y, Martelli MF. Tolerance induction by 'megadose' transplants of CD34 (+) stem cells: a new option for leukemia patients without an HLA-matched donor. Curr Opin Immunol 2000;12:536-41.
Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998;339:1186-93.
Holzer D, Gökbuget N. New approaches in acute lymphoblastic leukaemia in adults: Where do we go?. Semin Oncol 2000;27:540-59.
Terwey TH, Kim TD, Arnold R. Allogeneic hematopoietic stem cell transplantation for adult acute lymphocytic leukemia. Curr Hematol Malig Rep 2009;4:139-47.
Moalic V. Mobilization and collection of peripheral blood stem cells in healthy donors: Risks, adverse events and follow-up. Pathol Biol (Paris) 2013;61:70-4.
Körbling M. Collection of allogeneic peripheral blood stem cells. Baillieres Best Pract Res Clin Haematol. 1999;12(1- 2):41-55.
Alshemmari S, Ameen R, Gaziev J. Haploidentical hematopoietic stem cell transplantation in adults. Bone Marrow Res 2011;2011:303487.
Khoury HJ, Loberiza FR Jr, Ringdén O, Barrett AJ, Bolwell BJ, Cahn JY, et al. Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. Blood 2006;107:1712-16.